ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 255 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q3 2016. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $49,479,984 | +100.5% | 3,765,600 | +92.3% | 0.14% | +97.3% |
| Q2 2023 | $24,678,851 | +12843.8% | 1,958,639 | +13306.2% | 0.07% | +7200.0% |
| Q1 2023 | $190,661 | -97.3% | 14,610 | -96.4% | 0.00% | -95.8% |
| Q4 2022 | $7,089,516 | -52.5% | 401,900 | -59.0% | 0.02% | -60.0% |
| Q3 2022 | $14,935,000 | -19.6% | 980,600 | -21.7% | 0.06% | -23.1% |
| Q2 2022 | $18,578,000 | +1308.5% | 1,252,700 | +832.1% | 0.08% | +1014.3% |
| Q4 2019 | $1,319,000 | +265.4% | 134,400 | +308.5% | 0.01% | +250.0% |
| Q3 2019 | $361,000 | -66.4% | 32,900 | -70.8% | 0.00% | -60.0% |
| Q1 2019 | $1,073,000 | -62.4% | 112,495 | -43.8% | 0.01% | -58.3% |
| Q3 2018 | $2,850,000 | -59.9% | 200,000 | -64.1% | 0.01% | -70.0% |
| Q2 2017 | $7,107,000 | +55.1% | 557,000 | +60.1% | 0.04% | +25.0% |
| Q3 2016 | $4,582,000 | -67.5% | 347,900 | -70.5% | 0.03% | -66.7% |
| Q1 2015 | $14,083,000 | – | 1,177,500 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 1,375,000 | $20,006,000 | 10.92% |
| Adirondack Research & Management Inc. | 574,033 | $8,352,000 | 3.28% |
| GLENHILL ADVISORS LLC | 2,461,034 | $35,808,000 | 2.64% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,949,600 | $28,367,000 | 2.42% |
| DALTON GREINER HARTMAN MAHER & CO | 2,990,902 | $43,518,000 | 2.28% |
| S&T BANK/PA | 703,223 | $10,231,000 | 1.73% |
| Tibra Equities Europe Ltd | 263,344 | $3,832,000 | 1.64% |
| Millrace Asset Group, Inc. | 116,675 | $1,697,000 | 1.63% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 1,271,450 | $18,502,000 | 1.31% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,423,223 | $137,108,000 | 1.15% |